Shoulder Innovations, Inc. (SI) Return on Invested Capital (ROIC): -14.80%
Is Shoulder Innovations, Inc.’s return on invested capital (ROIC) high or low?
Shoulder Innovations, Inc.'s return on invested capital (ROIC) of -14.80% is 43% above its 2-year average of -25.91%, near the high end of its 2-year range (-41.24%–-14.80%).
As of Sunday, June 21, 2026. 47.18% above its 12-month average of -28.02%.
SI Return on Invested Capital (ROIC) Chart
SI Average Return on Invested Capital (ROIC) Chart
SI Current vs Average Return on Invested Capital (ROIC) Chart
SI Return on Invested Capital (ROIC) Metrics
RETURN ON INVESTED CAPITAL (ROIC)
-14.80%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-28.02%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+47.18%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SI Competitors' Return on Invested Capital (ROIC)
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Shoulder Innovations, Inc. (SI) | $384.69M | -14.80% | -28.02% | N/A | N/A |
| 23andMe Holding Co. (ME)vs › | $15.31M | -553.10% | -332.89% | -182.55% | -143.76% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.07B | 5.67% | -6.15% | -6.50% | -3.41% |
| TransMedics Group, Inc. (TMDX)vs › | $2.72B | 10.94% | 7.96% | -0.14% | -9.11% |
| Oscar Health, Inc. (OSCR)vs › | $7.36B | -27.10% | -12.21% | -19.73% | -18.73% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.64B | 2.04% | 2.21% | 2.35% | 2.39% |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.91B | 6.02% | 9.35% | -2.77% | -9.72% |
| Tempus AI, Inc. (TEM)vs › | $8.87B | -10.29% | -59.01% | -58.33% | -53.58% |
| Charles River Laboratories International, Inc. (CRL)vs › | $8.91B | 8.36% | 4.65% | 6.09% | 6.66% |
| Baxter International Inc. (BAX)vs › | $10.27B | -1.79% | -0.86% | -2.61% | 0.30% |
Capital Efficiency
ROIC
-14.8%
ROE
-33.1%
Shoulder Innovations, Inc. Return on Invested Capital (ROIC) Formula & Definition
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Shoulder Innovations, Inc. Return on Invested Capital (ROIC) FAQ
- What is the return on invested capital (ROIC) for Shoulder Innovations, Inc. (SI)?
- The return on invested capital (ROIC) for SI stock is -14.80%.
- Is Shoulder Innovations, Inc.'s return on invested capital (ROIC) high or low?
- Shoulder Innovations, Inc.'s return on invested capital (ROIC) of -14.80% is 43% above its 2-year average of -25.91%, near the high end of its 2-year range (-41.24%–-14.80%).
- What is the TTM average return on invested capital (ROIC) for Shoulder Innovations, Inc. (SI)?
- The TTM average return on invested capital (ROIC) for SI stock is -28.02%.
Shoulder Innovations, Inc. Return on Invested Capital (ROIC) History
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | -14.80% |
| 2024-12-31 | -41.24% |
| 2023-12-31 | -21.69% |
Related Metrics
About Shoulder Innovations, Inc.
Shoulder Innovations, Inc. is a medical technology firm that engineers and produces sophisticated devices. The company is particularly recognized for designing an innovative shoulder replacement system. Co-founded in 2009 by Stephen B. Gunther and Michael DeVries, its main corporate office is situated in Grand Rapids, Michigan.
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Alan J. Lane